Literature DB >> 26315378

Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.

Atsushi Kanoke1, Miki Fujimura2, Kuniyasu Niizuma1, Akira Ito1, Hiroyuki Sakata1, Mika Sato-Maeda1, Yuiko Morita-Fujimura3, Shigeo Kure4, Teiji Tominaga1.   

Abstract

Moyamoya disease (MMD) is a chronic, occlusive cerebrovascular disease with an unknown etiology. Recent genome-wide and locus-specific association studies identified the RNF213 gene (RNF213) as an important susceptibility gene of MMD among East Asian populations; however, the mechanism by which an abnormality in RNF213 leads to MMD has not yet been elucidated. Therefore, we herein generated Rnf213-knock-in mice (RNF213-KI) expressing a missense mutation in mouse Rnf213, p. R4828K, on Exon 61, corresponding to human RNF213, p. R4859K, on Exon 60, in MMD patients, and investigated whether they developed MMD. We assessed the temporal profile of intracranial arteries by 9.4-T magnetic resonance angiography (MRA) continuously in the same mouse up to 64 weeks of age. The ratios of the outer diameter of the internal carotid artery (ICA)/basilar artery (BA) and middle cerebral artery (MCA)/BA were evaluated histopathologically. The common carotid arteries (CCA) were sectioned and arterial wall thickness/thinness was evaluated by Elastica-Masson staining before and after CCA ligation, which selectively induced vascular hyperplasia. The results obtained showed that RNF213-KI grew normally, with no significant difference being observed in MRA findings or the anatomy of the circle of Willis between homozygous RNF213-KI and wild-type (Wt) littermates. Furthermore, no significant difference was noted in the diameter of the intracranial vasculature (ICA/BA; p=0.82, MCA/BA; p=0.27) or in vascular remodeling after CCA ligation. Therefore, RNF213-KI did not spontaneously develop MMD. Multiple secondary insults such as environmental factors may contribute to the onset of MMD in addition to genetic factors.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Knock-in mice; Magnetic resonance angiography (MRA); Moyamoya disease; RNF213

Mesh:

Substances:

Year:  2015        PMID: 26315378     DOI: 10.1016/j.brainres.2015.07.039

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

1.  Genome-Wide Association Study of Intracranial Artery Stenosis Followed by Phenome-Wide Association Study.

Authors:  Shogo Dofuku; Kyuto Sonehara; Satoru Miyawaki; Saori Sakaue; Hideaki Imai; Masahiro Shimizu; Hiroki Hongo; Yuki Shinya; Kenta Ohara; Yu Teranishi; Atsushi Okano; Hideaki Ono; Hirofumi Nakatomi; Akira Teraoka; Kenichi Yamamoto; Yuichi Maeda; Takuro Nii; Toshihiro Kishikawa; Ken Suzuki; Jun Hirata; Meiko Takahashi; Koichi Matsuda; Atsushi Kumanogoh; Fumihiko Matsuda; Yukinori Okada; Nobuhito Saito
Journal:  Transl Stroke Res       Date:  2022-06-14       Impact factor: 6.829

Review 2.  Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.

Authors:  Lei Cao; Yang Dong; Kaiwen Sun; Dongpeng Li; Hao Wang; Hongwei Li; Bo Yang
Journal:  Front Surg       Date:  2022-07-01

Review 3.  The Pathophysiology of Moyamoya Disease: An Update.

Authors:  Oh Young Bang; Miki Fujimura; Seung-Ki Kim
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

Review 4.  Role of Ring Finger Protein 213 in Moyamoya Disease.

Authors:  Yong-Gang Ma; Qian Zhang; Le-Bao Yu; Ji-Zong Zhao
Journal:  Chin Med J (Engl)       Date:  2016-10-20       Impact factor: 2.628

5.  Smaller outer diameter of atherosclerotic middle cerebral artery associated with RNF213 c.14576G>A Variant (rs112735431).

Authors:  Hiroki Hongo; Satoru Miyawaki; Hideaki Imai; Yuki Shinya; Hideaki Ono; Harushi Mori; Hirofumi Nakatomi; Akira Kunimatsu; Nobuhito Saito
Journal:  Surg Neurol Int       Date:  2017-06-05

Review 6.  Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.

Authors:  Takeshi Mikami; Hime Suzuki; Katsuya Komatsu; Nobuhiro Mikuni
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-07-06       Impact factor: 1.742

7.  Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study.

Authors:  Ryosuke Tashiro; Kuniyasu Niizuma; Seik-Soon Khor; Katsushi Tokunaga; Miki Fujimura; Hiroyuki Sakata; Hidenori Endo; Hidetoshi Inoko; Koetsu Ogasawara; Teiji Tominaga
Journal:  PLoS One       Date:  2019-08-14       Impact factor: 3.240

8.  Loss of mitochondrial ClpP, Lonp1, and Tfam triggers transcriptional induction of Rnf213, a susceptibility factor for moyamoya disease.

Authors:  Jana Key; Antonia Maletzko; Aneesha Kohli; Suzana Gispert; Sylvia Torres-Odio; Ilka Wittig; Juliana Heidler; Clea Bárcena; Carlos López-Otín; Yuanjiu Lei; A Phillip West; Christian Münch; Georg Auburger
Journal:  Neurogenetics       Date:  2020-04-28       Impact factor: 2.660

Review 9.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy.

Authors:  Oh Young Bang; Jong-Won Chung; Dong Hee Kim; Hong-Hee Won; Je Young Yeon; Chang-Seok Ki; Hyung Jin Shin; Jong-Soo Kim; Seung Chyul Hong; Duk-Kyung Kim; Akio Koizumi
Journal:  Transl Stroke Res       Date:  2019-10-24       Impact factor: 6.829

10.  Dysregulation of RNF213 promotes cerebral hypoperfusion.

Authors:  Takaaki Morimoto; Jun-Ichiro Enmi; Yorito Hattori; Satoshi Iguchi; Satoshi Saito; Kouji H Harada; Hiroko Okuda; Yohei Mineharu; Yasushi Takagi; Shohab Youssefian; Hidehiro Iida; Susumu Miyamoto; Masafumi Ihara; Hatasu Kobayashi; Akio Koizumi
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.